Patient Characteristics Associated with Receiving Gender-Affirming Hormone Therapy in the Veterans Health Administration.
Hill L WolfeVarsha G VimalanandaDenise H WongJoel I ReismanSowmya R RaoJillian C ShipherdJohn R BlosnichNicholas A LivingstonGuneet K JasujaPublished in: Transgender health (2024)
TGD individuals who were older, Black, non-Hispanic, and had more comorbidities and documented social stressors were less likely to receive gender-affirming hormone therapy in the VHA. Further understanding of patient preferences in addition to clinician- and site-level determinants that may impact access to gender-affirming hormone therapy for TGD individuals in the VHA is needed.